Even when providers are in network, a patient can be on the hook for thousands of dollars for common blood tests that are far cheaper in other settings. Here's one Texas woman's story.
Eli Lilly, Sanofi, and Novo Nordisk’s price cuts are expected to benefit many Texans who need insulin to survive. The companies first announced the moves last year, as a response to an American Rescue Plan provision that threatened to penalize them if they kept prices high.